research
A Bacterial Metabolite Helped the Gut Recover
Adding 10-HSA to antiretroviral therapy improved viral clearance and intestinal repair in a nonhuman-primate model.
Summary
Adding 10-HSA to antiretroviral therapy improved viral clearance and intestinal repair in a nonhuman-primate model.
UC Davis researchers tested 10-hydroxy-cis-12-octadecenoic acid, a metabolite associated with Lactobacillus plantarum, alongside antiretroviral therapy in nonhuman primates with SIV. The combination accelerated viral clearance and improved measures of gut-barrier repair compared with therapy alone. The result is preclinical, a patent has been filed and no human HIV benefit has yet been established.
Why it matters
Adding 10-HSA to antiretroviral therapy improved viral clearance and intestinal repair in a nonhuman-primate model.
Limits and context
- The result is preclinical, a patent has been filed and no human HIV benefit has yet been established.
Key claims
Adding 10-HSA to antiretroviral therapy improved viral clearance and intestinal repair in a nonhuman-primate model.
Qualification: The result is preclinical, a patent has been filed and no human HIV benefit has yet been established.
Evidence: source-2026-07-31-010
Sources
- UC Davis Health via Newswise: 10-HSA boosts HIV-treatment response in an animal modelUC Davis Health · secondary reporting
Corrections
No corrections have been recorded for this story.